Literature DB >> 17478641

Relational patterns of couples living with chronic pelvic pain from endometriosis.

Frances Strzempko Butt1, Catherine Chesla.   

Abstract

Chronic pelvic pain (CPP) is a disabling condition affecting 15 to 20% of U.S. women of reproductive age. Endometriosis, one of the most common causes of CPP, is associated with symptoms of pelvic pain, painful sexual intercourse, and infertility. In this qualitative study, the authors examined the relational impact of CPP from endometriosis on 13 couples through narrative interviews conducted individually and jointly. They describe five relational patterns that vary on degree of closeness, how care responsibilities are enacted, the degree to which couples are conjoined in their experiences, and how much their lives are overtaken with the disease. These patterns articulate couples' relational concerns as well as daily management of illness.

Entities:  

Mesh:

Year:  2007        PMID: 17478641     DOI: 10.1177/1049732307299907

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  14 in total

1.  The effect of peritoneal fluid from patients with endometriosis on mitochondrial function and development of early mouse embryos.

Authors:  Jing Shu; Lili Xing; Guolian Ding; Qiong Luo; Xinmei Liu; Qingfeng Yan; Jianzhong Sheng; Hefeng Huang
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

2.  The psychological profile of women presenting to a multidisciplinary clinic for chronic pelvic pain: high levels of psychological dysfunction and implications for practice.

Authors:  Christina Bryant; Rebecca Cockburn; Anne-Florence Plante; Angela Chia
Journal:  J Pain Res       Date:  2016-11-16       Impact factor: 3.133

3.  Patients with endometriosis using positive coping strategies have less depression, stress and pelvic pain.

Authors:  Lilian Donatti; Denise Gimenez Ramos; Marina de Paula Andres; Leigh Jonathan Passman; Sérgio Podgaec
Journal:  Einstein (Sao Paulo)       Date:  2017

4.  A qualitative study of the impact of endometriosis on male partners.

Authors:  L Culley; C Law; N Hudson; H Mitchell; E Denny; N Raine-Fenning
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

5.  Women's experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: a qualitative study.

Authors:  Elaine Denny; Annalise Weckesser; Georgina Jones; Stavroula Bibila; Jane Daniels; Siladitya Bhattacharya
Journal:  Pilot Feasibility Stud       Date:  2018-11-05

6.  Self-management in condition-specific health: a systematic review of the evidence among women diagnosed with endometriosis.

Authors:  Rebecca O'Hara; Heather Rowe; Jane Fisher
Journal:  BMC Womens Health       Date:  2019-06-19       Impact factor: 2.809

7.  Development and validation of the multidimensional vaginal penetration disorder questionnaire (MVPDQ) for assessment of lifelong vaginismus in a sample of Iranian women.

Authors:  Mitra Molaeinezhad; Robab Latifnejad Roudsari; Alireza Yousefy; Mehrdad Salehi; Effat Merghati Khoei
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

8.  Patients' and physicians' descriptions of occurrence and diagnosis of endometriosis: a qualitative study from Iran.

Authors:  Hedyeh Riazi; Najmeh Tehranian; Saeideh Ziaei; Easa Mohammadi; Ebrahim Hajizadeh; Ali Montazeri
Journal:  BMC Womens Health       Date:  2014-08-30       Impact factor: 2.809

9.  Fertility Outcome after Operative Laparoscopy versus No Treatment in Infertile Women with Minimal or Mild Endometriosis.

Authors:  Ashraf Moini; Laleh Bahar; Mansour Ashrafinia; Bita Eslami; Reihaneh Hosseini; Narges Ashrafinia
Journal:  Int J Fertil Steril       Date:  2012-03-20

10.  How do adolescent girls and boys perceive symptoms suggestive of endometriosis among their peers? Findings from focus group discussions in New York City.

Authors:  Jhumka Gupta; Lauren F Cardoso; Courtney S Harris; Arielle D Dance; Tamer Seckin; Nina Baker; Yvonne O Ferguson
Journal:  BMJ Open       Date:  2018-06-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.